je.st
news
Home
› Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-oncology Therapeutics
Astellas Pharma And Potenza Therapeutics Partner To Build A Portfolio Of Immuno-oncology Therapeutics
2015-04-29 04:14:33| drugdiscoveryonline Home Page
Astellas Pharma Inc. and Potenza Therapeutics, Inc., a biotechnology company developing a portfolio of immuno-oncology programs, recently announced an exclusive research and development collaboration
Tags: partner
build
portfolio
pharma
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||